aspiration (BMA) done on April 30, 2015, are shown in Figure 2 . He was also detected to have dilated cardiomyopathy (ejection fraction 45%). He had very high alkaline phosphatase-1,052 IU (attributed to liver infiltration). Direct antibody test was positive. After control of fever, he was initiated on prednisolone 1 mg/kg/day and cytopenias improved. On July 11, 2015, hemogram improved (Hb 10.7 gm/dL, WBC 8,770 /dL, platelets 1.07 lacs/dL). However, he had recurrence of fever and development of pancytopenia in September 2015 [Hb 5.5 mg/dL, WBC 3,000/cu mm, platelets-1 lac/cub mm, DLC P62, L24, M14]. He was started on chemoimmunotherapy with bendamustine, rituximab, and prednisolone (1 mg/kg/ day). Fever subsided and hemogram improved. Wysolone was tapered and 2nd cycle bendamustine and rituximab were given. Hemogram after 10 days was normal (Hb 11.2 gm/dL; WBC 4,000 cells/cub mm, platelets 2.72 lacs cells/cub mm.)
In current admission, which was 3 days after he was seen in outpatient department, he was admitted for fever, which was moderate-to-high grade associated with dysphagia to solids. He had no cough expectoration, chest pain, or urinary complaints.
Examination
He was conscious, cooperative, had respiratory rate of 24/minute, pulse 118/minute, blood pressure 106/60 mm Hg, O 2 saturation 98% room air, and mild pallor. No icterus, clubbing, pedal edema were noted and jugular venous pressure was normal.
He had generalized lymphadenopathy (1 cm cervical, axillary, inguinal). Chest examination: Normal breath sounds, Cardiovascular system: LVS3 gallop, abdomen: spleen 4 cm, Central nervous system: normal. • Fluorodeoxyglucose (FDG) avid lymph nodes both side of diaphragm and FDG avid marrow lesions as described-likely Richter transformation.
• Hepatosplenomegaly with FDG avid splenic lesion and lung nodule (Fig. 6 ).
Course and Management
This gentleman was diagnosed as a case of CLL (intermediate risk) in October 2014 and was kept under observation. In May 2015, he had an episode of sepsis (S. hominis related) with acute kidney injury and hemophagocytosis and recovered with prednisolone. However, because of recurrence of symptoms in August 2015, he was given chemoimmunotherapy with bendamustine and rituximab. He had prolonged neutropenia after 1st cycle of BR and second cycle of chemotherapy was given after a delay of 19 days in the last week of October 2015. Two weeks after second cycle of chemoimmunotherapy, patient developed febrile neutropenia, dysphagia, and acute kidney injury. Dysphagia was attributed to oral candidiasis (ear, nose, and throat evaluation, Ba swallow was normal, and dysphagia recovered after fluconazole). Patient received broad spectrum antibiotics (imipenem and teicoplanin) along with hemodialysis. However, patient developed progressive hypotension and succumbed to his illness on 21st November 2015.
Case Analysis
This gentleman had a rather quick progression of CLL and a stormy course of illness. The possible reasons for such a course in this patient are: Genetic abnormalities associated with CLL. This patient had 11 q deletion (ATM gene deletion) that is generally associated with extensive nodal involvement and worse prognosis. 1,2 Secondly, presence of advanced bone marrow fibrosis associated with significant anemia, thrombocytopenia, and 11 q deletion independently predicts prognosis. 3 Thirdly, presence of hemophagocytic lymphohistiocytosis might be masquerading as progressive CLL. 4 The reason for recurrent pancytopenia after partial recovery could be Richter transformation of CLL. Literature has highlighted that mature B cells seen in CLL can undergo transformation into Hodgkin-RS-like cells and express similar immunoprofile. 5 In addition, Epstein-Barr virus (EBV) has been detected in HRS-like cells indicating clonal expansion of EBV harboring B cell in the setting of CLL. The positron emission tomography computed tomography (PET CT) has a role in diagnosing Richter transformation. In one study, out of 11 patients with Richter transformation from CLL, 10 showed SUV max >5 6 and in another study, SUV max >13 was associated with Richter transformation. 7 Other complications in CLL can be infectious complications 8, 9 that are shown in Table 7 .
The possible reason for cardiomyopathy in this patient could be due to endocardial fibroelastosis that might have developed due to leukemic infiltration. 
Jpmer
To conclude, the febrile neutropenia might occur as a result of either accelerated transformation or Richter transformation of CLL and/or hemophagolymphohistiocytosis and/or due to chemotherapy. Sepsis would have occurred as a consequence of neutropenia that finally killed the patient.
Final Clinical Diagnosis
Chronic lymphocytic leukemia, progressive disease/ Richter transformation, on chemoimmunotherapy with BR, post 2nd cycle of BR, febrile neutropenia, acute kidney injury, dilated cardiomyopathy, refractory septic shock.
Clinical Discussion
Prof S Varma: Thank you Pankaj for the comprehensive discussion. In my opinion, I would consider HLH might be the terminal event in the patient apart from Richter transformation.
Now case is open for clinical discussion. Prof Sanjay Jain: Cardiomyopathy and proteinuria in this patient are not explainable. I bet on amyloid in this patient. Regarding chest, I consider possibility of tuberculosis.
Dr Gaurav: There is clinicomolecular miscorrelation in this patient. 11q deletion usually presents with bulky lymphadenopathy, which is not there in this patient.
Dr Dipesh: Evidence against HLH is absence of transaminitis in this patient.
Prof Subhash Varma: I can summarize the findings in this patient. This patient had unusual course of CLL. The BM has shown HLH which partially responded to steroids. Patient also has autoimmune disorder. Patient received course of chemotherapy and he developed acute kidney injury and sepsis. Candida infection was considered during admission and patient responded to fluconazole. Otherwise, we might have thought of other infections.
ECHO during admission does not show any features suggestive of amyloid. We do not have 24-hour urine output value.
With this information, I would request Prof Amanjit to demonstrate pathology of this case.
Pathology Findings
Antemortem lymph node biopsy (S-14771/2015) showed effacement of the normal nodal architecture. The infiltrate consisted of sheets of small lymphocytes with round nuclei, condensed chromatin, inconspicuous nucleoli, and scanty cytoplasm. These cells were positive for CD20, CD23, and CD5. Background showed CD3-positive reactive T cells. Interspersed in these neoplastic cells were large pleomorphic cells, which were positive for CD30 and PAX5, but negative for LCA. No Hodgkin's milieu noted. Thus, biopsy was labeled as CLL with ReedSternberg like cells (Figs 7 and 8) .
A partial autopsy was performed. On opening the serous cavities, peritoneal cavity yielded 1 L of fluid; however, pericardial and pleural cavities were within normal limits. SPLEEN: Weighed 940 gm; was enlarged and congested. Microscopy showed infiltration of atypical large lymphoid cells dominantly centered on white pulp and focal spillage into red pulp. The background showed histiocytes, mature lymphocytes, and plasma cells. Focal areas of necrosis with nuclear debri were also noted. Atypical cells were positive for CD30, CD15, PAX 5, but negative for CD20, CD3, LCA. Stain for AFB negative. In addition, there was evidence of hemophagocytosis (Fig. 9) . LIVER: Weighed 2.2 kg. Grossly, liver was enlarged. The capsular surface was normal; however, the cut surface showed diffuse grayish white nodularity. Gallbladder was not identified (staples seen at site). Portal and hepatic veins were normal. Microscopy revealed preserved lobular architecture. Portal tracts were expanded and showed infiltration by atypical large lymphoid cells in a background of histiocytes, mature lymphocytes, and plasma cells along with fibrosis. Focal areas of necrosis (Fig. 9) . EBV virus detection: The atypical cells were positive for EBV immunohistochemistry and Epstein-Barr encoded early RNA (EBER) ISH (Fig. 10) .
Overall features are of Hodgkin's Richter transformation in chronic lymphocytic leukemia (EBV associated).
BONE MARROW: There was adequate representation of all marrow elements. A few collections of atypical lymphoid cells positive for CD30 were noted. Mild increase in histiocytes with evidence of hemophagocytosis was also present.
LUNGS: Weighed 1,200 gm, grossly both lungs were heavy, and subcrepitent. The pleura was shiny and cut surface showed peribronchiolar greyish white nodular lesions. No thrombus was seen in the major pulmonary vessels. No enlarged lymph nodes noted (Figs 11A and B) . M/E: Sections from firm gray white lesions showed atypical lymphoid cells infiltrating the bronchial wall and peribronchiolar interstitium. These cells were positive for CD30. Focal areas of terminal bronchopneumonia and pulmonary edema were noted (Figs 11C and F) .
HEART: 350 mg. Gross: The heart was flabby and showed marked dilation of all four chambers. The right ventricular wall thickness was of 0.4 cm and left ventricular wall measures 1 cm. Valves were within normal limits, no vegetations seen ( Figs 12A and B) . Microscopy: showed mild endocardial fibrosis, variation in myocyte size, patchy perivascular interstitial fibrosis, and lack of inflammatory infiltrate ( Figs 12C and D) . Features were consistent with dilated cardiomyopathy. Aorta showed grade II atherosclerosis. Coronaries showed atherosclerotic changes with <50% occlusion of lumina. KIDNEYS: Together weighed 320 gm. Grossly few cortical cysts and blotchiness on the surface were noted. C/S showed distinct corticomedullary junction with medullary congestion (Fig. 13A) . On microscopy, glomeruli were unremarkable. Tubules showed presence of pigment casts (likely hemoglobin with fragmented RBCs) indicative of cast nephropathy. There was patchy interstitial fibrosis with fibrointimal proliferation of blood vessels (Fig. 13B) .
Pancreas, Esophagus, Stomach, Small and Large Intestine, Adrenal Glands, Testes, Prostate, Bladder: Did not show significant pathological changes.
FINAL AUTOPSY DIAGNOSIS (PM-27041)
A 66-year-old male with diagnosis of CLL: • Hodgkin's Richter transformation (EBV associated) (involving lymph nodes, liver, spleen, lungs, and bone marrow)
• Secondary hemophagocytosis • Dilated cardiomyopathy • Pigment cast nephropathy
Final Discussion
Prof S Varma; Yes Dr Gaurav, Dr Gaurav: Well, I would thank Dr Amanjit Bal for performing EBV ISH in this patient. That solved most of the problems in this case. One thing EBV infection caused only HL transformation not diffuse large B-cell lymphoma (DLBCL), and other it was responsible for HLH in this patient. Other thing I want to highlight is LDH is increased one and half times in this patient that additionally supports Richter transformation in this patient.
Prof Subhash Varma: Although Dr Gaurav told most of the riddles are solved but not exactly. HLH seen in this patient may be EBV related or malignancy related. Time period is short and patient would have changes from beginning rather than developing them later. Other riddle that is not solved in this patient is the cause for pigment cast nephropathy. He also stressed that patient definitely had acute hemolytic anemia that might be responsible for pigment in this patient.
Prof Sanjay: Although signs of transformation were seen clinically and pathologically, tumor load was not Prof Subhash Varma concluded that we had very interesting case for CPC.
SUMMARY
B-cell CLL is an indolent neoplasm of mature B cells. About 3 to 10% of these cases undergo Richter 's transformation and give rise to large cell lymphoma, most commonly DLBCL. However, in a minority of cases, transformation into Hodgkin's lymphoma is also well known. 10 In most instances, the Hodgkin's milieu on morphology and immunohistochemical features support a diagnosis of Hodgkin's lymphomatous transformation In few instances, similar clonal VH gene rearrangements were identified in HRS cells and B-CLL cells, suggesting that the two cell populations were derived from a common precursor B cell. However, in other cases, in which no clonal VH gene rearrangement was demonstrable, it was concluded that a germinal center B cell, which had already acquired somatic mutations gave rise to two cell populations, one of which developed into CLL while the other into HRS cells. 8 Evidence of EBV infection has also being documented either by EBV-LMP1 IHC or EBER ISH. Therefore, EBV infection may serve as a triggering event for the development of HRS cells in a background of CLL.
